Access to financial capital is critical to life sciences companies due to their R&D intensive efforts, regulatory and market access requirements. From bench to market, the different stages of commercialization require different sources of capital. This seminar will provide an overview of capital sources from venture capital and private equity, to senior debt and mezzanine financing. The event is ideally suited for business owners, business and corporate development executives, and financial specialists within the Life Sciences industry.


Jacki Jenuth, Principal at Lumira Capital

Brian Bloom, President of Bloom Burton & Co.

Nathalie Richard, Life Sciences & Health Services, RBC Royal Bank

Angelo Zeni, Director, Growth & Transition Capital, BDC

Moderator: Vanessa Grant, Partner at Gowlings

Date: Thursday, November 13, 2014


12:00-12:20 Lunch and Networking

12:20-1:10pm Insights

1:10-1:30 Open Discussion

1:30- Closing

Venue: MaRS, Room CR-3, 101 College Street, Toronto, ON, M5G1L7